查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000584

菸鹼醯胺市場：依形態、性質、應用和通路分類－2026-2032年全球預測

Niacinamide Market by Form, Nature, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，菸鹼醯胺市場價值將達到 7.8266 億美元，到 2026 年將成長至 8.2602 億美元，到 2032 年將達到 11.9026 億美元，年複合成長率為 6.17%。

主要市場統計數據
基準年 2025 7.8266億美元
預計年份：2026年 8.2602億美元
預測年份 2032 1,190,260,000 美元
複合年成長率 (%) 6.17%

簡潔策略概述，展現菸鹼醯胺在營養、化妝品、飼料和治療產品等生態系統中的多方面重要性。

菸鹼醯胺已從一種用途狹窄的成分發展成為一種多功能活性成分，其應用領域涵蓋營養、動物保健、化妝品和藥品等。作為維生素B3的重要形式，其功能多樣性——從支持皮膚屏障功能到在飼料和治療應用中發揮代謝作用——引起了配方研發人員、製造商和採購團隊的廣泛關注。本文將從現代市場需求促進因素和技術考量的觀點，概述此成分，以期為決策者提供重要參考。

消費者、監管和生產重點的變化如何重塑菸鹼醯胺的採購、配方和產品差異化策略。

受消費者期望、配方創新和供應鏈重組的驅動，菸鹼醯胺市場格局正經歷著變革性的轉變。隨著消費者對潔淨標示和多功能活性成分的需求日益成長，品牌商正​​將原料的透明度和可追溯性置於優先地位。同時，研發團隊正致力於開發能夠最佳化生物利用度和化妝品相容性的遞送系統。這些變化正在重塑競爭格局，迫使現有企業和新參與企業重新評估其產品宣傳和技術文件。

2025 年美國關稅制度對菸鹼醯胺供應鏈、籌資策略和生產通路選擇的影響。

美國在2025年實施的關稅措施迫使菸鹼醯胺價值鏈上的相關人員重新評估其採購管道和成本結構。貿易政策的變化凸顯了供應商組合多元化和緊急時應對計畫的重要性，尤其對於那些先前依賴特定原料來源的公司而言更是如此。因此，採購團隊正在審查合約條款，並考慮近岸外包和策略性庫存緩衝，以減輕運輸和關稅的衝擊。

全面的細分分析揭示了應用、形式、管道、最終用戶和材料特性的精確差異，從而指導技術和商業性優先排序。

有效的細分分析揭示了價值和風險在應用、形態、管道、最終用戶和材料特性等方面的集中程度。按應用領域分類，市場研究涵蓋動物飼料、化妝品、營養補充劑、食品飲料和藥品，其中動物飼料進一步細分為水產飼料、牛飼料、家禽飼料和豬飼料。化妝品細分為彩妝品、護髮和護膚，護膚又細分為抗衰老、美白和保濕等子類別。營養補充品依膠囊、液體、粉末和錠劑分析，食品飲料涵蓋烘焙產品、糖果甜點和乳製品，藥品區分非處方藥和處方藥。這種多層次的觀點清楚地闡明了技術規範和監管要求差異最大的領域。

影響美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和監管細微差別，以及這些趨勢和差異如何影響採購、合規和商業策略。

區域趨勢對菸鹼醯胺的需求模式、法規環境和供應鏈路徑有顯著影響。在美洲，商業活動主要由面向消費者的個人保健產品創新以及蓬勃發展的膳食補充劑和藥品市場驅動，這些市場強調臨床證據和標籤透明度。該地區的供應重點在於增強韌性和遵守法規，促使製造商採取嚴格的品管，並優先考慮從原料到成品的可追溯性。

競爭趨勢表明，技術差異化、監管合規能力和供應可靠性決定了菸鹼醯胺供應商的領導地位。

競爭格局呈現出原料專家、化學品製造商和垂直整合供應商並存的局面，各方都採取不同的策略來獲取價值。大型製造商透過技術嚴謹性脫穎而出，例如提供詳細的雜質譜、客製化的顆粒設計和針對特定應用的等級產品；而其他製造商則專注於規模和成本競爭力。原料供應商與品牌配方製造商之間的策略合作日益普遍，雙方可以共同開發穩定系統和專有配方，從而提升特定應用領域的效能。

為相關人員制定可操作的策略重點，以增強採購韌性、加快配方開發、改善監管和永續地位。

產業領導企業應採取積極主動、全面全面的方法，以保持菸鹼醯胺市場的韌性並抓住成長機會。首先，籌資策略應與技術和監管要求保持一致，具體做法是將總到岸成本分析、供應商審核和多地點合約納入採購手冊。這將有助於最大限度地降低貿易中斷帶來的風險，同時確保配方性能符合要求。其次，應增加對特定應用領域的研發投入，開發出滿足化妝品、營養補充劑配方以及特定飼料應用所需的穩定性、溶解性和感官特性目標的差異化等級產品。

為了得出確切的結論，我們採用了一種高度透明的混合方法研究途徑，該方法結合了對負責人的初步訪談、技術文獻綜述以及使用三角測量法的數據分析。

本分析所依據的研究結合了定性和定量方法，旨在全面涵蓋技術、商業性和監管方面。研究人員對配方、採購、法規遵循和供應鏈等領域的行業從業人員進行了結構化訪談，作為主要資訊來源，從而獲得了關於技術規範、籌資策略和市場需求的第一手觀點。除訪談外，研究人員還與個人護理、膳食補充劑、製藥、食品飲料和飼料行業的製造商和終端用戶進行了有針對性的對話，以收集特定應用領域的見解。

整合策略挑戰，展示技術嚴謹性、採購系統和監管準備如何決定菸鹼醯胺的商業性成功。

菸鹼醯胺在營養、健康和個人照護領域佔據著策略性地位，其技術性能、法規遵循和供應鏈韌性在此交匯融合。該分析一再強調了以下幾個主題：高度重視原料來源和雜質控制、針對特定應用的配方具有商業性價值，以及應對貿易和物流波動性的營運需求。這些主題表明，市場更青睞那些能夠將嚴謹的科學方法與切實可行的供應策略結合的公司。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 菸鹼醯胺市場：依形式分類

  • 膠囊
  • 液體
  • 粉末
  • 藥片

第9章：菸鹼醯胺市場：依特性分類

  • 自然的
    • 植物來源
    • 酵母衍生的
  • 合成
    • 生物合成
    • 石油化工衍生性商品

第10章：菸鹼醯胺市場：依應用領域分類

  • 動物飼料
    • 水產飼料
    • 牛飼料
    • 家禽飼料
    • 豬飼料
  • 化妝品
    • 彩妝
    • 護髮
    • 護膚
      • 抗衰老
      • 美白
      • 保濕
  • 營養補充品
    • 膠囊
    • 液體
    • 粉末
    • 藥片
  • 食品/飲料
    • 麵包店
    • 糖果甜點
    • 乳製品
  • 製藥
    • 非處方藥
    • 處方藥

第11章 菸鹼醯胺市場：依分銷管道分類

  • 電子商務
    • 企業網站
    • 第三方平台
  • 實體零售
    • 藥局和藥局
    • 專賣店
    • 超級市場和大賣場

第12章 菸鹼醯胺市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 菸鹼醯胺市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 菸鹼醯胺市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國菸鹼醯胺市場

第16章：中國菸鹼醯胺市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Bactolac Pharmaceutical, Inc.
  • BASF SE
  • Brother Enterprises Holding Co., Ltd.
  • Evonik Industries AG
  • Hefei TNJ Chemical Co., Ltd.
  • Jubilant Life Sciences Ltd.
  • Koninklijke DSM NV
  • Lasons India Pvt. Ltd.
  • Lonza Group AG
  • Merck KGaA
  • Nantong Acetic Acid Chemical Co., Ltd.
  • Resonance Specialties Ltd.
  • Roquette Freres
  • Shandong Pharmaceutical Group Co., Ltd.
  • Shanghai Lixin Biochemical Technology Co., Ltd.
  • Vertellus Holdings LLC
  • Wuhan Grand Harvest Biotech Co., Ltd.
  • Zhejiang Medicine Co., Ltd.
Product Code: MRR-9E01E2DC4AC3

The Niacinamide Market was valued at USD 782.66 million in 2025 and is projected to grow to USD 826.02 million in 2026, with a CAGR of 6.17%, reaching USD 1,190.26 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 782.66 million
Estimated Year [2026] USD 826.02 million
Forecast Year [2032] USD 1,190.26 million
CAGR (%) 6.17%

A concise strategic orientation to niacinamide that frames its multidisciplinary relevance across nutrition, cosmetics, feed, and therapeutic product ecosystems

Niacinamide has evolved from a narrowly focused ingredient to a multifaceted active that intersects nutrition, animal health, cosmetics, and pharmaceuticals. As an essential form of vitamin B3, its functional versatility-ranging from skin barrier support to metabolic roles in feed and therapeutic applications-has expanded interest among formulators, manufacturers, and procurement teams. This introduction frames the ingredient through the lens of contemporary demand drivers and technical considerations that matter to decision-makers.

Industry stakeholders are now navigating a more complex landscape where consumer claims, regulatory scrutiny, supply chain resilience, and raw material provenance exert simultaneous influence on product strategy. Consequently, product managers and R&D leaders must reconcile shelf-life and formulation stability with sensory and efficacy expectations. At the same time, procurement and supply chain professionals must address feedstock origin, synthesis pathways, and potential trade frictions that affect availability and cost basis.

This section sets the stage for the deeper analysis that follows by highlighting how niacinamide's cross-sector relevance necessitates integrated planning. It underscores the importance of placing scientific evidence, regulatory alignment, and sourcing strategy at the center of commercial planning to preserve brand trust and meet evolving market requirements.

How evolving consumer, regulatory, and manufacturing priorities are reshaping niacinamide sourcing, formulation, and product differentiation strategies

The niacinamide landscape is experiencing transformative shifts driven by consumer expectations, formulation innovation, and supply chain reconfiguration. Rising demand for clean-label and multifunctional actives is prompting brands to prioritize ingredient transparency and traceability, while R&D teams invest in delivery systems that optimize bioavailability and cosmetic compatibility. Those changes are reshaping the competitive set and forcing incumbents and new entrants alike to rethink product narratives and technical dossiers.

Simultaneously, regulatory trends and quality expectations have tightened, encouraging manufacturers to adopt higher standards for impurity profiling and certificates of analysis. As a result, material specifications and vendor audits have gained prominence in sourcing strategies. Parallel to these quality-focused changes, advances in manufacturing-particularly bio-synthetic methods and improved crystallization or granulation techniques-are enabling producers to differentiate on particle properties, solubility, and sensory profile, thus broadening application potential.

These shifts also amplify the importance of cross-functional collaboration; product developers must coordinate with regulatory affairs and procurement to translate technical advantages into compliant claims and reliable supply. The net effect is an industry that rewards transparency, technical rigor, and the ability to rapidly translate emerging science into scalable formulations.

Implications of the 2025 United States tariff regime on niacinamide supply chains, procurement strategies, and manufacturing pathway choices

The introduction of tariff measures in the United States in 2025 has compelled stakeholders across the niacinamide value chain to reassess sourcing routes and cost structures. Trade policy changes have heightened the need for diversified supplier portfolios and contingency planning, especially for companies that previously relied on concentrated sources of raw materials. Procurement teams are therefore recalibrating contracts and exploring nearshoring or strategic inventory buffers to mitigate transit and duty-related disruptions.

Beyond immediate cost implications, these tariffs are influencing long-term supplier selection and contractual terms. Buyers are placing greater emphasis on total landed cost analysis, which incorporates duties, logistics variability, and inventory holding costs, rather than focusing solely on headline unit prices. This shift is prompting some manufacturers to pursue vertically integrated strategies or to secure multi-origin contracts that can be flexed according to duty regimes and logistical constraints.

In parallel, the tariff environment is accelerating interest in alternative manufacturing pathways. Firms are evaluating the technical and commercial viability of bio-synthetic routes, vegetable-derived processes, and localized investment to reduce exposure to cross-border friction. From a strategic perspective, companies that proactively redesign supply chains and adjust commercial models will be better positioned to preserve margin and ensure continuity of supply in a more protectionist trade climate.

Comprehensive segmentation analysis revealing precise application, form, channel, end user, and material nature distinctions that guide technical and commercial prioritization

Effective segmentation analysis illuminates where value and risk concentrate across applications, forms, channels, end users, and material nature. Based on Application, the market is studied across Animal Feed, Cosmetics, Dietary Supplements, Food And Beverage, and Pharmaceuticals, with Animal Feed further subdivided into Aquaculture Feed, Cattle Feed, Poultry Feed, and Swine Feed; Cosmetics is elaborated into Color Cosmetics, Hair Care, and Skin Care, and Skin Care is explored through Anti-Aging, Brightening, and Moisturizing subsegments. Dietary Supplements are analyzed by Capsules, Liquid, Powder, and Tablets, while Food And Beverage considers Bakery, Confectionery, and Dairy, and Pharmaceuticals differentiates Over-The-Counter Drugs from Prescription Drugs. This multi-layered view clarifies where technical specification and regulatory expectation vary most dramatically.

Based on Form, the market is studied across Capsules, Liquid, Powder, and Tablets, a segmentation that shapes considerations such as dissolution behavior, storage stability, and compatibility with co-formulants. Based on Distribution Channel, the market is studied across E-Commerce and Offline Retail, with E-Commerce further delineated into Company Website and Third-Party Platforms and Offline Retail elaborated as Pharmacies And Drug Stores, Specialty Stores, and Supermarkets And Hypermarkets; channel choice influences packaging, labeling, and promotional strategies along with regulatory compliance in different territories. Based on End User, the market is studied across Feed Manufacturers, Food And Beverage Manufacturers, Personal Care Manufacturers, and Pharmaceutical Manufacturers, each bringing distinct technical specifications and procurement protocols.

Based on Nature, the market is studied across Natural and Synthetic, with Natural further differentiated into Vegetable-Derived and Yeast-Derived sources and Synthetic subdivided into Bio-Synthetic and Petrochemical-Sourced pathways. Understanding these distinctions enables stakeholders to tailor purity requirements, sustainability messaging, and supply continuity plans. Together, these segmentation layers provide a roadmap for prioritizing product development, regulatory submissions, and commercial positioning based on where technical attributes and buyer expectations align most tightly.

Regional dynamics and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence sourcing, compliance, and commercial strategy

Regional dynamics materially shape demand patterns, regulatory contexts, and supply chain pathways for niacinamide. In the Americas, commercial activity is driven by a blend of consumer-facing personal care innovation and a robust supplement and pharmaceutical market that emphasizes clinical substantiation and label transparency. Supply considerations in this region also favor resilience and regulatory alignment, prompting manufacturers to adopt stringent quality controls and to emphasize traceability from feedstock to finished good.

Europe, Middle East & Africa presents a heterogeneous regulatory and commercial landscape where ingredient provenance, sustainability credentials, and safety dossiers carry significant weight. High regulatory thresholds in several European markets require detailed impurity profiles and compliance with advanced cosmetic and pharmaceutical directives, while growing markets in the Middle East and Africa prioritize affordability and scalable supply, creating diverse opportunities for different value propositions.

Asia-Pacific exhibits rapid innovation and production capacity expansion, underpinned by strong manufacturing ecosystems and a fast-moving consumer base that often adopts new formulations quickly. This region combines advanced technical capabilities with growing domestic demand across personal care, dietary supplements, and feed applications. Across these geographies, firms must tailor regulatory strategies, supply chain architectures, and marketing narratives to local expectations while maintaining global consistency in quality and safety.

Competitive dynamics showing how technical differentiation, regulatory capability, and supply reliability define leadership among niacinamide suppliers

The competitive landscape is characterized by a mix of ingredient specialists, chemical producers, and vertically integrated suppliers, each pursuing different strategies to capture value. Leading producers differentiate through technical rigor-offering detailed impurity profiles, customized particle engineering, and application-specific grades-while others emphasize scale and cost competitiveness. Strategic partnerships between ingredient suppliers and brand formulators are becoming more common, allowing for co-development of stabilized systems and proprietary formulations that deliver enhanced performance for targeted applications.

Innovation is also driving consolidated service offerings, where companies combine regulatory support, dossier preparation, and supply continuity assurances to address customer concerns holistically. In addition, several firms are investing in sustainability claims, traceability solutions, and certifications that validate source attribution, particularly for products positioned as natural or vegetable-derived. These investments are not only marketing differentiators but also risk mitigation tools as buyers increasingly demand chain-of-custody information.

Smaller, nimble players are carving niches by targeting specialized application needs-such as ultra-pure grades for pharmaceuticals or sensory-optimized grades for premium cosmetics-while larger firms leverage global footprints to offer multi-origin supply and scale benefits. Collectively, these dynamics create a market where technical capability, regulatory competence, and supply reliability determine competitive positioning.

Actionable strategic priorities for stakeholders to strengthen sourcing resilience, accelerate formulation innovation, and enhance regulatory and sustainability positioning

Industry leaders should adopt a proactive, integrated approach to maintain resilience and capture growth opportunities in the niacinamide market. First, align sourcing strategy with technical and regulatory requirements by integrating total landed cost analysis, supplier audits, and multi-origin contracts into procurement playbooks. This will minimize exposure to trade disruptions while preserving formulation performance expectations. Second, invest in application-specific R&D to create differentiated grades that address stability, solubility, and sensory objectives in cosmetics, formulations for dietary supplements, and targeted feed applications.

Third, strengthen regulatory and quality assurance capabilities by standardizing impurity profiling, expanding dossier completeness, and adopting transparent labeling practices that enhance customer confidence. Fourth, prioritize sustainability and traceability initiatives-such as validated source documentation for vegetable-derived or yeast-derived inputs and credible carbon or stewardship claims-to support premium positioning and meet evolving customer expectations. Fifth, explore strategic partnerships and co-development agreements with brand owners to accelerate route-to-market for novel formulations and to ensure alignment between technical claims and real-world performance.

Finally, implement scenario-based planning that accounts for tariff volatility, logistics interruptions, and raw material availability. By combining technical differentiation with operational agility and rigorous compliance, companies can simultaneously mitigate risk and unlock new opportunities across multiple application segments.

A transparent mixed-methods research approach blending primary practitioner interviews, technical literature review, and triangulated data analysis to ensure robust conclusions

The research underpinning this analysis combines qualitative and quantitative approaches designed to ensure comprehensive coverage of technical, commercial, and regulatory dimensions. Primary inputs included structured interviews with industry practitioners across formulation, procurement, regulatory affairs, and supply chain roles, providing first-hand perspectives on technical specifications, sourcing strategies, and market needs. These interviews were complemented by targeted engagement with manufacturers and end users across personal care, dietary supplements, pharmaceuticals, food and beverage, and feed sectors to capture application-specific insights.

Secondary inputs included peer-reviewed scientific literature, regulatory documentation, and technical white papers that informed discussions on impurity profiling, manufacturing pathways, and formulation best practices. Trade data and customs documentation were examined to identify shifts in flows and to contextualize discussions about duty impacts and logistic constraints. Cross-validation techniques were employed to reconcile differing viewpoints and to triangulate the most robust findings.

Analysis methods prioritized transparency and reproducibility. Technical assertions were corroborated with multiple independent sources, and methodological assumptions were documented to support interpretability by technical and commercial audiences. Wherever applicable, sensitivity assessments were conducted to illustrate how changes in trade policy, feedstock origin, or manufacturing pathways could influence strategic decision-making.

Synthesis of strategic imperatives showing how technical rigor, procurement discipline, and regulatory readiness together determine commercial success in niacinamide

Niacinamide occupies a strategic intersection of nutrition, health, and personal care where technical performance, regulatory compliance, and supply chain resilience converge. Throughout this analysis, recurring themes emerged: the premium placed on material provenance and impurity control, the commercial value of application-specific formulations, and the operational need to manage trade and logistical volatility. These themes point to a market that rewards companies capable of integrating scientific rigor with pragmatic supply strategies.

Looking across applications and geographies, it becomes clear that success will favor organizations that can deliver consistent quality at a competitive total cost while responding nimbly to regulatory variation and evolving consumer expectations. Those that invest in differentiated product grades, transparent sourcing narratives, and targeted partnerships will be better positioned to meet the nuanced demands of cosmetics formulators, supplement manufacturers, feed producers, and pharmaceutical clients.

In summary, the evolutionary trajectory of the niacinamide market underscores the importance of aligning R&D priorities with procurement discipline and regulatory readiness. By doing so, stakeholders can turn technical strengths into commercial advantage and build resilient operations that accommodate both short-term disruptions and long-term shifts in demand.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Niacinamide Market, by Form

  • 8.1. Capsules
  • 8.2. Liquid
  • 8.3. Powder
  • 8.4. Tablets

9. Niacinamide Market, by Nature

  • 9.1. Natural
    • 9.1.1. Vegetable-Derived
    • 9.1.2. Yeast-Derived
  • 9.2. Synthetic
    • 9.2.1. Bio-Synthetic
    • 9.2.2. Petrochemical-Sourced

10. Niacinamide Market, by Application

  • 10.1. Animal Feed
    • 10.1.1. Aquaculture Feed
    • 10.1.2. Cattle Feed
    • 10.1.3. Poultry Feed
    • 10.1.4. Swine Feed
  • 10.2. Cosmetics
    • 10.2.1. Color Cosmetics
    • 10.2.2. Hair Care
    • 10.2.3. Skin Care
      • 10.2.3.1. Anti-Aging
      • 10.2.3.2. Brightening
      • 10.2.3.3. Moisturizing
  • 10.3. Dietary Supplements
    • 10.3.1. Capsules
    • 10.3.2. Liquid
    • 10.3.3. Powder
    • 10.3.4. Tablets
  • 10.4. Food And Beverage
    • 10.4.1. Bakery
    • 10.4.2. Confectionery
    • 10.4.3. Dairy
  • 10.5. Pharmaceuticals
    • 10.5.1. Over-The-Counter Drugs
    • 10.5.2. Prescription Drugs

11. Niacinamide Market, by Distribution Channel

  • 11.1. E-Commerce
    • 11.1.1. Company Website
    • 11.1.2. Third-Party Platforms
  • 11.2. Offline Retail
    • 11.2.1. Pharmacies And Drug Stores
    • 11.2.2. Specialty Stores
    • 11.2.3. Supermarkets And Hypermarkets

12. Niacinamide Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Niacinamide Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Niacinamide Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Niacinamide Market

16. China Niacinamide Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Bactolac Pharmaceutical, Inc.
  • 17.6. BASF SE
  • 17.7. Brother Enterprises Holding Co., Ltd.
  • 17.8. Evonik Industries AG
  • 17.9. Hefei TNJ Chemical Co., Ltd.
  • 17.10. Jubilant Life Sciences Ltd.
  • 17.11. Koninklijke DSM N.V.
  • 17.12. Lasons India Pvt. Ltd.
  • 17.13. Lonza Group AG
  • 17.14. Merck KGaA
  • 17.15. Nantong Acetic Acid Chemical Co., Ltd.
  • 17.16. Resonance Specialties Ltd.
  • 17.17. Roquette Freres
  • 17.18. Shandong Pharmaceutical Group Co., Ltd.
  • 17.19. Shanghai Lixin Biochemical Technology Co., Ltd.
  • 17.20. Vertellus Holdings LLC
  • 17.21. Wuhan Grand Harvest Biotech Co., Ltd.
  • 17.22. Zhejiang Medicine Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS NIACINAMIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL NIACINAMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 276. GCC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. GCC NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 278. GCC NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 279. GCC NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 280. GCC NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 281. GCC NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. GCC NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 283. GCC NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 284. GCC NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 285. GCC NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 286. GCC NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 287. GCC NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 288. GCC NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 289. GCC NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 290. GCC NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 320. BRICS NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 321. G7 NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 322. G7 NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 323. G7 NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 324. G7 NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 325. G7 NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 326. G7 NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 327. G7 NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 328. G7 NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 329. G7 NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 330. G7 NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 331. G7 NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 332. G7 NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 333. G7 NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 334. G7 NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 335. G7 NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 336. NATO NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 337. NATO NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 338. NATO NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 339. NATO NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 340. NATO NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 341. NATO NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 342. NATO NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 343. NATO NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 344. NATO NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 345. NATO NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 346. NATO NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 347. NATO NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 348. NATO NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 349. NATO NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 350. NATO NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 351. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
  • TABLE 359. UNITED STATES NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 360. UNITED STATES NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 361. UNITED STATES NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
  • TABLE 362. UNITED STATES NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 363. UNITED STATES NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 364. UNITED STATES NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 365. UNITED STATES NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 366. UNITED STATES NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 367. CHINA NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 368. CHINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)

T